Description
The comprehensive Conference program will present the latest developments in basic, clinical and translational research, and reinforce the underlying need for multidisciplinary collaboration in the treatment of lung cancer.
This is a critical moment in the field of lung cancer. New strategies for multidisciplinary approaches are becoming more important; pharmacogenomic research and clinical trials including genetic assessment are advancing at a great pace. In order to keep abreast of the latest developments in basic, clinical and translational research, the 2nd 2nd European Lung Cancer Conference 2010 is THE thoracic CME conference to attend.
